ID   PKHG3_HUMAN             Reviewed;        1219 AA.
AC   A1L390; A1L389; B5MEC9; O60339; Q6GMS3; Q6P4B1; Q7L3S3; Q86SW7; Q8TEF5;
AC   Q96EW6; Q9BT82;
DT   02-OCT-2007, integrated into UniProtKB/Swiss-Prot.
DT   06-FEB-2007, sequence version 1.
DT   28-JUN-2023, entry version 128.
DE   RecName: Full=Pleckstrin homology domain-containing family G member 3;
DE            Short=PH domain-containing family G member 3 {ECO:0000305};
GN   Name=PLEKHG3 {ECO:0000312|HGNC:HGNC:20364}; Synonyms=KIAA0599;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S., Sun H.,
RA   Du H., Pepin K., Artiguenave F., Robert C., Cruaud C., Bruels T.,
RA   Jaillon O., Friedlander L., Samson G., Brottier P., Cure S., Segurens B.,
RA   Aniere F., Samain S., Crespeau H., Abbasi N., Aiach N., Boscus D.,
RA   Dickhoff R., Dors M., Dubois I., Friedman C., Gouyvenoux M., James R.,
RA   Madan A., Mairey-Estrada B., Mangenot S., Martins N., Menard M., Oztas S.,
RA   Ratcliffe A., Shaffer T., Trask B., Vacherie B., Bellemere C., Belser C.,
RA   Besnard-Gonnet M., Bartol-Mavel D., Boutard M., Briez-Silla S.,
RA   Combette S., Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C.,
RA   Muselet D., Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P.,
RA   Trybou A., Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L., Verdier J.,
RA   Verdier-Discala C., Hillier L.W., Fulton L., McPherson J., Matsuda F.,
RA   Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W., Quetier F.,
RA   Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANT
RP   TRP-1036.
RC   TISSUE=Brain, Lung, Pancreas, and Urinary bladder;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-659 (ISOFORM 3).
RC   TISSUE=Cervix carcinoma;
RA   Li W.B., Gruber C., Jessee J., Polayes D.;
RT   "Full-length cDNA libraries and normalization.";
RL   Submitted (FEB-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 177-1219 (ISOFORM 1).
RC   TISSUE=Spleen;
RA   Jikuya H., Takano J., Nomura N., Kikuno R., Nagase T., Ohara O.;
RT   "The nucleotide sequence of a long cDNA clone isolated from human spleen.";
RL   Submitted (JAN-2002) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 523-1219.
RC   TISSUE=Brain;
RX   PubMed=9455484; DOI=10.1093/dnares/4.5.345;
RA   Seki N., Ohira M., Nagase T., Ishikawa K., Miyajima N., Nakajima D.,
RA   Nomura N., Ohara O.;
RT   "Characterization of cDNA clones in size-fractionated cDNA libraries from
RT   human brain.";
RL   DNA Res. 4:345-349(1997).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-76; SER-576; SER-577;
RP   SER-643; SER-647; SER-741; SER-962; SER-1037 AND SER-1040, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-76; SER-576; SER-577;
RP   SER-1037 AND SER-1040, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-76; SER-576; SER-577;
RP   SER-631; SER-640; SER-643; SER-647; SER-741; SER-827; SER-1037 AND
RP   SER-1040, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-76; SER-631; SER-640;
RP   SER-643; SER-647; SER-741; SER-827; SER-1037; SER-1040 AND SER-1081, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-741 AND SER-1011, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [12]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-1107, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.o113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M.,
RA   Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V.,
RA   Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [13]
RP   SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=27555588; DOI=10.1073/pnas.1604720113;
RA   Nguyen T.T., Park W.S., Park B.O., Kim C.Y., Oh Y., Kim J.M., Choi H.,
RA   Kyung T., Kim C.H., Lee G., Hahn K.M., Meyer T., Heo W.D.;
RT   "PLEKHG3 enhances polarized cell migration by activating actin filaments at
RT   the cell front.";
RL   Proc. Natl. Acad. Sci. U.S.A. 113:10091-10096(2016).
CC   -!- FUNCTION: Plays a role in controlling cell polarity and cell motility
CC       by selectively binding newly polymerized actin and activating RAC1 and
CC       CDC42 to enhance local actin polymerization.
CC       {ECO:0000269|PubMed:27555588}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton
CC       {ECO:0000269|PubMed:27555588}. Note=Colocalizes with actin at the
CC       leading edge of polarized cells. {ECO:0000269|PubMed:27555588}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=A1L390-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=A1L390-2; Sequence=VSP_028533, VSP_041513;
CC       Name=3;
CC         IsoId=A1L390-3; Sequence=VSP_028534;
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB84995.1; Type=Miscellaneous discrepancy; Note=Intron retention. There are two regions of intron retention within the sequence which cause it to shift frame.; Evidence={ECO:0000305};
CC       Sequence=CAD66586.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL121774; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC004298; AAH04298.1; -; mRNA.
DR   EMBL; BC011891; AAH11891.2; -; mRNA.
DR   EMBL; BC063554; AAH63554.1; -; mRNA.
DR   EMBL; BC073907; AAH73907.1; -; mRNA.
DR   EMBL; BC129952; AAI29953.1; -; mRNA.
DR   EMBL; BC129953; AAI29954.1; -; mRNA.
DR   EMBL; BX248779; CAD66586.1; ALT_INIT; mRNA.
DR   EMBL; AK074169; BAB84995.1; ALT_SEQ; mRNA.
DR   EMBL; AB011171; BAA25525.1; -; mRNA.
DR   CCDS; CCDS76690.1; -. [A1L390-1]
DR   PIR; T00267; T00267.
DR   RefSeq; NP_001295076.1; NM_001308147.1. [A1L390-1]
DR   RefSeq; XP_016876646.1; XM_017021157.1.
DR   AlphaFoldDB; A1L390; -.
DR   SMR; A1L390; -.
DR   BioGRID; 117496; 108.
DR   IntAct; A1L390; 41.
DR   MINT; A1L390; -.
DR   STRING; 9606.ENSP00000247226; -.
DR   iPTMnet; A1L390; -.
DR   PhosphoSitePlus; A1L390; -.
DR   BioMuta; PLEKHG3; -.
DR   EPD; A1L390; -.
DR   jPOST; A1L390; -.
DR   MassIVE; A1L390; -.
DR   MaxQB; A1L390; -.
DR   PeptideAtlas; A1L390; -.
DR   ProteomicsDB; 140; -. [A1L390-1]
DR   ProteomicsDB; 141; -. [A1L390-2]
DR   ProteomicsDB; 142; -. [A1L390-3]
DR   Antibodypedia; 57155; 82 antibodies from 11 providers.
DR   DNASU; 26030; -.
DR   Ensembl; ENST00000247226.13; ENSP00000247226.8; ENSG00000126822.18. [A1L390-1]
DR   Ensembl; ENST00000394691.7; ENSP00000378183.2; ENSG00000126822.18. [A1L390-3]
DR   GeneID; 26030; -.
DR   KEGG; hsa:26030; -.
DR   MANE-Select; ENST00000247226.13; ENSP00000247226.8; NM_001308147.2; NP_001295076.1.
DR   UCSC; uc001xhn.2; human. [A1L390-1]
DR   AGR; HGNC:20364; -.
DR   CTD; 26030; -.
DR   DisGeNET; 26030; -.
DR   GeneCards; PLEKHG3; -.
DR   HGNC; HGNC:20364; PLEKHG3.
DR   HPA; ENSG00000126822; Tissue enhanced (brain).
DR   MIM; 617940; gene.
DR   neXtProt; NX_A1L390; -.
DR   OpenTargets; ENSG00000126822; -.
DR   PharmGKB; PA134925358; -.
DR   VEuPathDB; HostDB:ENSG00000126822; -.
DR   eggNOG; KOG3518; Eukaryota.
DR   GeneTree; ENSGT00940000156521; -.
DR   HOGENOM; CLU_007600_0_0_1; -.
DR   InParanoid; A1L390; -.
DR   OMA; IVKMWER; -.
DR   OrthoDB; 5400510at2759; -.
DR   PhylomeDB; A1L390; -.
DR   TreeFam; TF328565; -.
DR   PathwayCommons; A1L390; -.
DR   Reactome; R-HSA-8980692; RHOA GTPase cycle.
DR   Reactome; R-HSA-9013148; CDC42 GTPase cycle.
DR   Reactome; R-HSA-9013149; RAC1 GTPase cycle.
DR   Reactome; R-HSA-9013406; RHOQ GTPase cycle.
DR   Reactome; R-HSA-9013408; RHOG GTPase cycle.
DR   SignaLink; A1L390; -.
DR   SIGNOR; A1L390; -.
DR   BioGRID-ORCS; 26030; 123 hits in 1144 CRISPR screens.
DR   GenomeRNAi; 26030; -.
DR   Pharos; A1L390; Tbio.
DR   PRO; PR:A1L390; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   RNAct; A1L390; protein.
DR   Bgee; ENSG00000126822; Expressed in sural nerve and 169 other tissues.
DR   ExpressionAtlas; A1L390; baseline and differential.
DR   Genevisible; A1L390; HS.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0003779; F:actin binding; IDA:UniProtKB.
DR   GO; GO:0005085; F:guanyl-nucleotide exchange factor activity; IBA:GO_Central.
DR   GO; GO:0031267; F:small GTPase binding; IBA:GO_Central.
DR   GO; GO:0030334; P:regulation of cell migration; IMP:UniProtKB.
DR   GO; GO:2000114; P:regulation of establishment of cell polarity; IDA:UniProtKB.
DR   GO; GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome.
DR   CDD; cd13243; PH_PLEKHG1_G2_G3; 1.
DR   CDD; cd00160; RhoGEF; 1.
DR   Gene3D; 1.20.900.10; Dbl homology (DH) domain; 1.
DR   Gene3D; 2.30.29.30; Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB); 1.
DR   InterPro; IPR035899; DBL_dom_sf.
DR   InterPro; IPR000219; DH-domain.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR043324; PH_PLEKHG1_G2_G3.
DR   PANTHER; PTHR45924; FI17866P1; 1.
DR   PANTHER; PTHR45924:SF4; PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING FAMILY G MEMBER 3; 1.
DR   Pfam; PF00169; PH; 1.
DR   Pfam; PF00621; RhoGEF; 1.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00325; RhoGEF; 1.
DR   SUPFAM; SSF48065; DBL homology domain (DH-domain); 1.
DR   SUPFAM; SSF50729; PH domain-like; 1.
DR   PROSITE; PS50010; DH_2; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cytoplasm; Cytoskeleton; Methylation; Phosphoprotein;
KW   Reference proteome.
FT   CHAIN           1..1219
FT                   /note="Pleckstrin homology domain-containing family G
FT                   member 3"
FT                   /id="PRO_0000306863"
FT   DOMAIN          93..272
FT                   /note="DH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00062"
FT   DOMAIN          296..394
FT                   /note="PH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00145"
FT   REGION          1..66
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          431..599
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          613..708
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          756..780
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          821..840
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          859..878
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          955..1133
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1146..1207
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        446..481
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        482..499
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        528..542
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        613..645
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        861..875
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1004..1044
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1054..1068
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1158..1187
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         76
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         433
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q4VAC9"
FT   MOD_RES         576
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692"
FT   MOD_RES         577
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692"
FT   MOD_RES         618
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q4VAC9"
FT   MOD_RES         631
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         640
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         643
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163"
FT   MOD_RES         647
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163"
FT   MOD_RES         741
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         779
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q4VAC9"
FT   MOD_RES         827
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         962
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         1011
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         1023
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q4VAC9"
FT   MOD_RES         1037
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         1040
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         1081
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         1107
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   VAR_SEQ         1..466
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_028533"
FT   VAR_SEQ         118..173
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|Ref.3"
FT                   /id="VSP_028534"
FT   VAR_SEQ         467..468
FT                   /note="MK -> M (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_041513"
FT   VARIANT         1014
FT                   /note="R -> H (in dbSNP:rs41309246)"
FT                   /id="VAR_061518"
FT   VARIANT         1036
FT                   /note="R -> W (in dbSNP:rs229649)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_035330"
FT   CONFLICT        443..468
FT                   /note="QGRRQSEPTKHLLRQLNEKARAAGMK -> KGAGPEPPGSEEEEEEQEESLA
FT                   VAEQ (in Ref. 2; AAH04298)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        461..468
FT                   /note="KARAAGMK -> ESLAVAEQ (in Ref. 2; AAH73907)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        723..736
FT                   /note="YYENAEHHDAGFSV -> WWPHCTPASCSSPT (in Ref. 2;
FT                   AAH04298)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        921
FT                   /note="R -> S (in Ref. 2; AAI29953)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1219 AA;  134412 MW;  DAEB5673340F4FBD CRC64;
     MPVSTSLHQD GSQERPVSLT STTSSSGSSC DSRSAMEEPS SSEAPAKNGA GSLRSRHLPN
     SNNNSSSWLN VKGPLSPFNS RAAAGPAHHK LSYLGRVVRE IVETERMYVQ DLRSIVEDYL
     LKIIDTPGLL KPEQVSALFG NIENIYALNS QLLRDLDSCN SDPVAVASCF VERSQEFDIY
     TQYCNNYPNS VAALTECMRD KQQAKFFRDR QELLQHSLPL GSYLLKPVQR ILKYHLLLQE
     IAKHFDEEED GFEVVEDAID TMTCVAWYIN DMKRRHEHAV RLQEIQSLLI NWKGPDLTTY
     GELVLEGTFR VHRVRNERTF FLFDKTLLIT KKRGDHFVYK GNIPCSSLML IESTRDSLCF
     TVTHYKHSKQ QYSIQAKTVE EKRNWTHHIK RLILENHHAT IPQKAKEAIL EMDSYYPNRY
     RCSPERLKKA WSSQDEVSTN VRQGRRQSEP TKHLLRQLNE KARAAGMKGK GRRESESSRS
     SRRPSGRSPT STEKRMSFES ISSLPEVEPD PEAGSEQEVF SAVEGPSAEE TPSDTESPEV
     LETQLDAHQG LLGMDPPGDM VDFVAAESTE DLKALSSEEE EEMGGAAQEP ESLLPPSVLD
     QASVIAERFV SSFSRRSSVA QEDSKSSGFG SPRLVSRSSS VLSLEGSEKG LARHGSATDS
     LSCQLSPEVD ISVGVATEDS PSVNGMEPPS PGCPVEPDRS SCKKKESALS TRDRLLLDKI
     KSYYENAEHH DAGFSVRRRE SLSYIPKGLV RNSISRFNSL PRPDPEPVPP VGSKRQVGSR
     PTSWALFELP GPSQAVKGDP PPISDAEFRP SSEIVKIWEG MESSGGSPGK GPGQGQANGF
     DLHEPLFILE EHELGAITEE SATASPESSS PTEGRSPAHL ARELKELVKE LSSSTQGELV
     APLHPRIVQL SHVMDSHVSE RVKNKVYQLA RQYSLRIKSN KPVMARPPLQ WEKVAPERDG
     KSPTVPCLQE EAGEPLGGKG KRKPVLSLFD YEQLMAQEHS PPKPSSAGEM SPQRFFFNPS
     AVSQRTTSPG GRPSARSPLS PTETFSWPDV RELCSKYASR DEARRAGGGR PRGPPVNRSH
     SVPENMVEPP LSGRVGRCRS LSTKRGRGGG EAAQSPGPLP QSKPDGGETL YVTADLTLED
     NRRVIVMEKG PLPSPTAGLE ESSGQGPSSP VALLGQVQDF QQSAECQPKE EGSRDPADPS
     QQGRVRNLRE KFQALNSVG
//
